(Q43679875)

25 November 2017

title

Selectivity enhancement induced by substitution of non-natural analogues of arginine and lysine in arginine-based thrombin inhibitors (English)

1 reference

25 November 2017

Kokko KP

1

1 reference

25 November 2017

Arrigoni CE

series ordinal

2

1 reference

25 November 2017

Dix TA

series ordinal

3

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

Bioorganic & Medicinal Chemistry Letters

25 November 2017

published in

1 reference

25 November 2017

volume

11

1 reference

25 November 2017

issue

14

1 reference

25 November 2017

page(s)

1947-1950

1 reference

Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900328-6

7 January 2021

Design rationale, synthesis, and characterization of non-natural analogs of the cationic amino acids arginine and lysine

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900328-6

7 January 2021

Preparation and receptor binding affinities of cyclic C-terminal neurotensin (8-13) and (9-13) analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900328-6

7 January 2021

Synthesis and human neurotensin receptor binding activities of neurotensin(8-13) analogues containing position 8 alpha-azido-N-alkylated derivatives of ornithine, lysine, and homolysine

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900328-6

7 January 2021

Synthesis of neurotensin(9-13) analogues exhibiting enhanced human neurotensin receptor binding affinities

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900328-6

7 January 2021

Thrombin inhibitors. 2. Amide derivatives of N alpha-substituted L-arginine

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900328-6

7 January 2021

Active site-directed thrombin inhibitors-II. Studies related to arginine/guanidine bioisosteres

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900328-6

7 January 2021

Design of highly potent noncovalent thrombin inhibitors that utilize a novel lipophilic binding pocket in the thrombin active site

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900328-6

7 January 2021

Design and synthesis of a series of potent and orally bioavailable noncovalent thrombin inhibitors that utilize nonbasic groups in the P1 position

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900328-6

7 January 2021

Discovery and development of the novel potent orally active thrombin inhibitor N-(9-hydroxy-9-fluorenecarboxy)prolyl trans-4-aminocyclohexylmethyl amide (L-372,460): coapplication of structure-based design and rapid multiple analogue synthesis on so

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900328-6

7 January 2021

Design of novel, potent, noncovalent inhibitors of thrombin with nonbasic P-1 substructures: rapid structure-activity studies by solid-phase synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900328-6

7 January 2021

Polarization of the fluorescence of macromolecules. I. Theory and experimental method

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900328-6

7 January 2021

10.1016/S0960-894X(01)00328-6

Identifiers

DOI

1 reference

25 November 2017

1 reference